EMR - Emerson Electric Shares Plummet On Q4 Miss CEO Expects NI Deal To Solve Challenges | Benzinga
Emerson Electric Co (NYSE: EMR) reported fourth-quarter (Q4) FY23 net sales growth of 5% year-over-year to $4.09 billion, missing the consensus of $4.19 billion.
Q3 Underlying sales and orders were up 5% Y/Y.
Adjusted EPS improved 21% Y/Y to $1.29, missing the consensus of $1.31.
Sales by Segments: Final Control $1.08 billion (+8% Y/Y), Measurement & Analytical $1.05 billion (+15% Y/Y), Discrete Automation $666 million (-8% Y/Y); Safety & Productivity $354 million (+4% Y/Y), Control Systems & Software $714 million (+3% Y/Y), and AspenTech $249 million (-1% Y/Y).
Emerson's operating cash ...